Skip to main content
Article thumbnail
Location of Repository

Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes

By James R Lupski and Pawel Stankiewicz

Abstract

Rearrangements of our genome can be responsible for inherited as well as sporadic traits. The analyses of chromosome breakpoints in the proximal short arm of Chromosome 17 (17p) reveal nonallelic homologous recombination (NAHR) as a major mechanism for recurrent rearrangements whereas nonhomologous end-joining (NHEJ) can be responsible for many of the nonrecurrent rearrangements. Genome architectural features consisting of low-copy repeats (LCRs), or segmental duplications, can stimulate and mediate NAHR, and there are hotspots for the crossovers within the LCRs. Rearrangements introduce variation into our genome for selection to act upon and as such serve an evolutionary function analogous to base pair changes. Genomic rearrangements may cause Mendelian diseases, produce complex traits such as behaviors, or represent benign polymorphic changes. The mechanisms by which rearrangements convey phenotypes are diverse and include gene dosage, gene interruption, generation of a fusion gene, position effects, unmasking of recessive coding region mutations (single nucleotide polymorphisms, SNPs, in coding DNA) or other functional SNPs, and perhaps by effects on transvection

Topics: Review
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:1352149
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome.
    2. (2005). A common inversion under selection in Europeans.
    3. (1996). A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element.
    4. (1998). A selective difference between human Y-chromosomal DNA haplotypes.
    5. (2003). An Alu transposition model for the origin and expansion of human segmental duplications.
    6. (2002). Analysis of 22 deletion breakpoints in dystrophin intron 49.
    7. (2004). Applications of genomic microarrays to explore human chromosome structure and function.
    8. (2004). As normal as normal can be?
    9. (2004). Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
    10. (1994). Bacterial genomes: Mapping and stability.
    11. (2004). Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2).
    12. (2004). Breakpoints of gross deletions coincide with non-B DNA conformations.
    13. (1992). Charcot-MarieTooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit.
    14. (1998). Chi sites and their consequences.
    15. (1993). Conservation and evolution of the rpsU-dnaG-rpoD macromolecular synthesis operon in bacteria.
    16. (2003). Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture.
    17. (1988). Dependence of intrachromosomal recombination in mammalian cells on uninterrupted homology.
    18. (2004). Detection of large-scale variation in the human genome.
    19. (1993). DNA deletion associated with hereditary neuropathy with liability to pressure palsies.
    20. (1991). DNA duplication associated with Charcot-Marie-Tooth disease type 1A.
    21. Elsas LJ 2nd, Devriendt K, Elsea SH (2005) RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.
    22. (2004). Evidence for substantial fine-scale variation in recombination rates across the human genome.
    23. Garcia A (2001) Charcot-Marie-Tooth peripheral neuropathies and related disorders.
    24. (2002). Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2.
    25. (2003). Genome architecture catalyzes nonrecurrent chromosomal rearrangements.
    26. (2002). Genome architecture, rearrangements and genomic disorders.
    27. (2004). Genome Sequencing Consortium
    28. (1998). Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits.
    29. (2003). Genomic inversions of human chromosome 15q11-q13 in mothers of Angelman syndrome patients with class II (BP2/3) deletions.
    30. (2002). Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.
    31. (2005). Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: The CMT1A duplication and HNPP deletion.
    32. (2002). Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation.
    33. (1997). Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome.
    34. (1987). Homology requirement for efficient gene conversion between duplicated chromosomal sequences in mammalian cells.
    35. (2004). Hotspots of homologous recombination in the human genome: Not all homolgous sequences are equal.
    36. (2004). Implications of human genome architecture for rearrangement-based disorders: The genomic basis of disease.
    37. (2005). Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.
    38. (2005). Interphase FISH screening for the LCR-mediated common rearrangement of isochromosome 17q in primary myelofirosis.
    39. (1986). Interstitial deletion of (17)(p11.2p11.2) in nine patients.
    40. (1986). Interstitial deletion of (17)(p11.2p11.2): Report of six additional patients with a new chromosome deletion syndrome.
    41. (1999). Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations.
    42. (2004). Large-scale copy number polymorphism in the human genome.
    43. (2005). Long-range control of gene expression: Emerging mechanisms and disruption in disease.
    44. (2003). Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: Phenotypic consequences of gene dosage imbalance.
    45. (1996). Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients.
    46. (1991). Molecular analysis of the Smith-Magenis syndrome: A possible contiguous-gene syndrome associated with del(17)(p11.2).
    47. (2001). Molecular cytogenetics of contiguous gene syndromes: Mechanisms and consequences.
    48. (2000). Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion.
    49. (1996). Multidisciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2).
    50. (2003). Mutations in RAI1 associated with Smith-Magenis syndrome.
    51. (2004). Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.
    52. (2005). Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms.
    53. (2005). Phenotypic consequences of genetic variation at hemizygous alleles: Sotos syndrome is a contiguous gene syndrome incorporating coagulation factor twelve (FXII) deficiency.
    54. (2005). Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia.
    55. (1999). Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: Molecular mechanism and phenotypic manifestations.
    56. (1996). Quantification by flow cytometry of chromosome-17 deletions in SmithMagenis syndrome patients.
    57. (2001). Recent duplication, domain accretion and the dynamic mutation of the human genome.
    58. (2003). Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2.
    59. (2004). Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
    60. (2005). Segmental duplications and copy-number variation in the human genome.
    61. (2001). Segmental duplications: Organization and impact within the current human genome project assembly.
    62. (2004). Small marker chromosomes in two patients with segmental aneusomy for proximal 17p.
    63. (2005). Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol.
    64. (2002). Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs.
    65. (2004). The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats.
    66. (2004). The fine-scale structure of recombination rate variation in the human genome.
    67. (1996). The Smith-Magenis syndrome [del(17)p11.2]: Clinical review and molecular advances.
    68. (2003). Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    69. (2005). Trisomy 17p10-p12 due to mosaic supernumery marker chromosome: Delineation of molecular breakpoints and clinical phenotype and comparison to other proximal 17p segmental duplications.
    70. (2001). Trisomy 17p10-p12 resulting from a supernumerary marker chromosome derived from chromosome 17: Molecular analysis and delineation of the phenotype.
    71. (1994). Two autosomal dominant neuropathies result from reciprocal DNA duplication/ deletion of a region on chromosome 17.
    72. (2004). Uncommon deletions of the SmithMagenis syndrome region can be recurrent when alternate low-copy repeats act as homologous recombination substrates.
    73. (2003). Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)].
    74. (2004). Where the crossovers are: Recombination distributions in mammals.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.